Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Ophthalmic Eye Drop Market Outlook from 2024 to 2034

The global ophthalmic eye drop market is expected to grow from US$ 17,271.8 million in 2024 to US$ 25,876.4 million by 2034. By 2034, the market is projected to surge at 4.7% CAGR. The ophthalmic eye drop market was valued at US$ 16,390.6 million in 2023 and is anticipated to exhibit a y-o-y growth of 5.4% in 2024.

Attributes Key Insights
Base Value (2023) US$ 16,390.6 million
Estimated Global Ophthalmic Eye Drop Market Size (2024E) US$ 17,271.8 million
Projected Ophthalmic Eye Drop Market Value (2034F) US$ 25,876.4 million
Value-based CAGR (2024 to 2034) 4.7%

Increasing prevalence of eye disorders such as cataracts, glaucoma, dry eye syndrome, and allergies is surging the demand for ophthalmic eye drops. Rising global population age and growing incidence of eye-related conditions are acting as a catalyst triggering ophthalmic eye drop sales.

Growing global elderly population is expected to boost demand for ophthalmic eye drops. Their preference for self-administered eye care products also contributes to the ophthalmic eye drop market growth.

The rise in eye health awareness and regular eye examinations is expected to surge demand for ophthalmic eye drops, leading to earlier diagnosis and treatment of eye conditions. This is creating opportunities for eye care providers and manufacturers of ophthalmic products, including eye drops.

Advanced drug delivery systems and formulation technologies provide a positive outlook for the market. The introduction of preservative-free eye drops and innovative drug delivery techniques is driving growth of the ophthalmic eye drop industry.

The rise of e-commerce platforms fuels the accessibility of eye care products, including eye drops, to consumers worldwide. The market's growth is attributed to the ease of online purchasing and doorstep delivery, especially in regions with limited access to physical retail stores.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2019 to 2023 Ophthalmic Eye Drop Market Growth Outlook Vs. 2024 to 2034

The global ophthalmic eye drop market recorded a historical CAGR of 4.3% from 2019 to 2023. Historical factors contributing to the remarkable growth of the ophthalmic eye drop market were attributed to the development of advanced ophthalmic drug delivery technologies. These technologies have significantly enhanced drug delivery efficiency, ensuring more effective treatment outcomes.

The market has benefited from a diversification of therapeutic approaches that specifically target various dry eye symptoms. This innovative approach has broadened the range of available treatments and improved the effectiveness of addressing diverse eye conditions.

Furthermore, strategic collaborations among key manufacturers have played a crucial role in fostering product development and creating a dynamic and competitive market environment.

Futuristic factors impacting market dynamics include a continued emphasis on innovative drug delivery technologies and a focus on enhancing precision & patient adherence. Strategic collaborations are likely to persist, fostering the development of novel products in the market.

Collaborative efforts between manufacturers are expected to lead to synergies in research and development, enabling innovative solutions that address emerging concerns in the market. These collaborations are set to facilitate the pooling of resources and enhance the collective expertise, enabling the development of more advanced and tailored therapeutic approaches.

Insights into Lucrative Opportunities Propelling Ophthalmic Eye Drop Market

Increasing research and development activities in the market are expected to contribute to the global ophthalmic eye drop market's growth during the forecast period. Both public and private market players are investing heavily in developing affordable, accessible, and effective generic ophthalmic drugs to improve community health.

Nanoparticle-based drug formulations offer a promising alternative, improving ocular permeability, prolonging residence time, and stabilizing medicines. This technology is gaining popularity for its ability to enhance bioavailability and accommodate various pharmaceuticals.

With a rising emphasis on research and development, the ophthalmic eye drop market is poised for significant growth. Nanotechnology-driven advancements offer opportunities to enhance drug efficacy and meet the growing demand for innovative eye treatments, driving expansion in the market.

Government initiatives play a pivotal role in propelling growth of the ophthalmic eye drop market. For instance, an impactful resolution passed by the UN General Assembly in July 2021 signifies a concerted commitment to intensify efforts in addressing the escalating impact of vision loss on sustainable development.

Furthermore, it emphasizes the integration of comprehensive eye care services into universal health coverage, reflecting a holistic approach to prioritizing eye health on a global scale.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Overview of Restrictive Factors for the Ophthalmic Eye Drop Market

With a growing middle class and increased access to eye care services, the demand for ophthalmologists is growing rapidly. However, the shortage of ophthalmologists is expected to hinder the field of prescription-based ophthalmic eye drops.

There is a growing need to increase access and raise awareness among populations to get their eyes checked regularly, as lack of awareness is set to lead to immediate and long-term consequences.

Inadequate infrastructure and healthcare facilities, particularly in rural areas, are set to limit access to eye care services, including ophthalmic eye drops. Limited healthcare financing and investment in developing economies are expected to impede the development and distribution of ophthalmic eye drops.

Comparative View of Adjacent Markets

A comprehensive analysis of growth and challenges has been tabulated below. The ophthalmic eye drop market is compared with two industries that have the potential to compete rigorously: the eye infection treatment market and the ophthalmic laser market.

Growth rates and key market trends are mentioned in the table below. Among the mentioned markets, the ophthalmic laser market is poised to rise more rapidly during the forecast period.

Ophthalmic Eye Drop Market:

Attributes Ophthalmic Eye Drop Market
CAGR (2024 to 2034) 4.7%
Ophthalmic Eye Drop Market Opportunities Market expansion is being driven by the availability of self-administration over-the-counter eye drops and growing awareness of eye health's importance.
Key Trends Growth of the eye drop industry is influenced by technological advancements in pharmaceutical formulations and medication delivery systems, enhancing their efficacy and safety.

Eye Infection Treatment Market:

Attributes Eye Infection Treatment Market
CAGR (2024 to 2034) 3.8%
Growth Factor Eye drops for conjunctivitis, pink eye, stye, and keratitis are expected to see high demand in the forecast period, with providers launching new products to boost revenues.
Key Trends Eye infection treatment providers are focusing on developing new diagnostic and treatment procedures to reduce infection risks, with technological advancements expected to significantly influence the market in the future.

Ophthalmic Laser Market:

Attributes Ophthalmic Laser Market
CAGR (2024 to 2034) 5.4%
Growth Factor Patients opt for refractive surgeries and laser eye surgery due to high success rates, thereby triggering future growth in the ophthalmic laser market.
Key Trends Demand for ophthalmic lasers is expected to increase due to the growing preference for minimally invasive procedures and innovations in ophthalmology.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

The table below shows the estimated growth rates of the top five countries. The United Kingdom, China, and Japan are set to record high CAGRs of 5.4%, 6.6%, and 6.2%, respectively, through 2034.

Countries Value CAGR (2024 to 2034)
United States 5.0%
China 6.6%
Germany 1.8%
United Kingdom 5.4%
Japan 6.2%

Rising Use of Contact Lenses to Augment Sales in the United States

The United States ophthalmic eye drop industry is poised to exhibit a CAGR of 5.0% during the forecast period. The rise in contact lens usage, driven by high focus on appearance and the adoption of active lifestyles, is heightening the risk of ocular infections in the United States.

According to the Centers for Disease Control and Prevention, 45 million adults in the United States wear contact lenses. Alarmingly, 99% of contact lens users exhibit at least one risky hygiene behavior, increasing their susceptibility to eye infections or irritations.

Increasing prevalence of eye infections due to the growing adoption of contact lenses is expected to drive the demand for ophthalmic eye drops in the United States.

Booming Pharmaceutical Industry in China to Sure Demand for Ophthalmic Eye Drops

Ophthalmic eye drop demand in China is anticipated to rise at a steady CAGR of 6.6% during the forecast period. Burgeoning development of the pharmaceutical industry in China is significantly bolstering the ophthalmic eye drop market.

As China's pharmaceutical sector continues to expand rapidly, there is a notable upswing in the production and innovation of ophthalmic medications, including eye drops. This surge not only meets the increasing domestic demand for eye care but also positions China as a key player in the global ophthalmic market.

The confluence of robust pharmaceutical growth and heightened focus on ocular health is poised to propel the ophthalmic eye drop market to new heights. It is projected to create favorable conditions for sustained expansion and advancements in the industry.

Germany to be the Next-door Opportunity for Key Manufacturers

The ophthalmic eye drop market is projected to increase in Germany at a CAGR of 1.8% through 2034. Germany has witnessed a surging awareness concerning eye health, propelling market growth.

The heightened consciousness around ocular well-being is driving demand for eye care products, notably contributing to growth of the ophthalmic eye drop market. This trend reflects a positive shift in consumer behavior toward prioritizing eye health, thereby creating a favorable environment for market expansion.

As Germany continues to place a premium on eye care, the market is poised for sustained growth, with the potential for further advancements and innovations in the ophthalmic products and treatments field.

Category-wise Insights

The section below shows the steroid drops segment dominating by product. The segment is predicted to surge at a CAGR of 4.8% through 2034. Based on drug formulation, the with preservative segment is anticipated to generate a dominant share through 2024. It is set to rise at a CAGR of 4.1% through 2034.

Segment Value CAGR (2024 to 2034)
Steroid Drops (Products) 4.8%
Multiple-Dose Container (Container Type) 4.3%
With Preservative (Drug Formulation) 4.1%
Dry Eye (Indication) 2.2%

Steroid Drops Emerge as Market Frontrunner, Spearheading Product Categories

Steroid drops dominated the global market with a 26.0% share in 2023 and are projected to continue experiencing high growth throughout the forecast period. The widespread adoption of steroid eye drops in ophthalmology primarily stems from their crucial role in managing postoperative inflammation.

Steroid drops are indispensable tools for controlling inflammatory responses following surgical procedures, ensuring optimal recovery, and minimizing complications. Furthermore, their integral role extends to addressing immune hyperactivity conditions, including non-infectious uveitis, graft rejection, and allergic disorders such as atopic or vernal keratoconjunctivitis.

Dry Eye Segment Predicted to Garner a Significant Share in 2024

The escalating prevalence of dry eye has become a notable concern in recent years, posing a significant growth for the market. Rising awareness and diagnosis of dry eye are contributing to the rising adoption of ophthalmic eye drops.

As more individuals recognize and report irritation, redness, and discomfort associated with dry eye, demand for ophthalmic eye drops is expected to surge.

Competitive Landscape

In the dynamic ophthalmic eye drop market landscape, companies strategically emphasize collaborations, partnerships, and continuous product launches. These initiatives reflect the industry's commitment to innovation, addressing evolving market demands, and staying competitive. Instances of key developmental strategies by industry players in the ophthalmic eye drop market are given below:

  • In May 2023, Bausch & Lomb and Novaliq jointly announced that MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) received FDA approval for effectively treating the signs and symptoms associated with dry eye disease.
  • In May 2021, Scope Eyecare and URSAPHARM Arzneimittel GmbH announced a collaboration to produce a co-branded product line for dry eye products in the United States. The OPTASE® HYLO® range was created to fulfill the needs of dry eye patients in the United States.

Key Companies Profiled

  • Allergan
  • Novartis AG (Sandoz Inc.)
  • Alcon Laboratories, Inc.
  • Bausch Health US LLC
  • Viatris Inc.
  • Teva Pharmaceuticals
  • Sun Pharmaceutical Industries, Inc.
  • URSAPHARM Arzneimittel GmbH
  • Lupin Biomedical Group
  • Biomedical Group
  • AdvaCare Pharma
  • Dompé Farmaceutici S.p.A

Key Coverage in Global Ophthalmic Eye Drop Market Research Report

  • Adjacent Study on Global Eye and Face Protection Market, Ophthalmic Diagnostic Equipment Market, and Diabetes care Devices Market
  • Ophthalmic Eye Drop Market Share, Size, and Landscape
  • The Future of Ophthalmic Eye Drop
  • Reasons Behind the Growing Popularity of Ophthalmic Eye Drop
  • Ophthalmic Eye Drop Market Landscape with Special Focus on New Launches
  • List of Ophthalmic Eye Drop in the United States

Ophthalmic Eye Drop Industry Segmentation by Category

By Product:

  • Anesthetic Drops
  • Dilation Drops
  • Glaucoma Drops
  • Steroid Drops
  • Antibiotic Drops
  • Others

By Indication:

  • Dry Eye
  • Eye Allergy
  • Glaucoma
  • Eye Infection
  • Retinal Disorders
    • Macular Degeneration
    • Diabetic Retinopathy
    • Others
  • Uveitis
  • Others

By Drug Formulation:

  • With Preservative
  • Preservative Free

By Container Type:

  • Single Dose Container
  • Multiple-dose Container

By Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Ophthalmic Clinics
    • Public Health Agencies
    • Veterinary Hospitals & Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Mail Order Pharmacy

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • Middle East and Africa

Frequently Asked Questions

How big is the ophthalmic eye drop market?

The market is set to reach US$ 17,271.8 million in 2024.

What is the forecast for the ophthalmic eye drop market?

Demand for ophthalmic eye drops is slated to expand at a 4.7% CAGR through 2034.

What is the outlook for the ophthalmic eye drop market?

The market is set to reach US$ 25,876.4 million in 2034.

Who are the key players in the ophthalmic eye drop market?

Allergan, Alcon Laboratories, Inc., and Bausch Health US LLC are the key players.

Which drug formulation would lead the ophthalmic eye drop market?

With preservation segment is estimated to hold a significant market share in 2024.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption Analysis, by Region

    4.2. Disease Epidemiology, by Region

    4.3. Regulatory Scenario

        4.3.1. Legal Requirements and Frameworks in the United States

        4.3.2. Legal Requirements and Frameworks in the Europe

        4.3.3. Legal Requirements and Frameworks in the China

        4.3.4. Legal Requirements and Frameworks in the Japan

        4.3.5. Legal Requirements and Frameworks in the India

        4.3.6. Legal Requirements and Frameworks in the Australia

    4.4. Porter’s Analysis

    4.5. PESTLE Analysis

    4.6. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. Global R&D Funding, by Region

        5.1.3. Pharmaceutical Spending, by Key Countries

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. GDP Growth

        5.2.2. Prevalence of Ophthalmic Disorders

        5.2.3. Diagnosis Rate

        5.2.4. Treatment Seeking Rate

        5.2.5. Treatment Pattern

        5.2.6. Overall Treatment Cost

        5.2.7. Aging Population

        5.2.8. Strategic Merger & Acquisition

        5.2.9. Emergence of new pathogen variants

        5.2.10. Increasing cases of post-operative eye infections

        5.2.11. Top Companies Historical growth

        5.2.12. Patient Preferences and Awareness

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Product

    6.2. Pricing Assumptions

7. Global Market Demand (in Value in US$ million) and Volume (Th Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    7.1. Historical Market Value (US$ million) and Volume (Th Units) Analysis, 2019 to 2023

    7.2. Current and Future Market Size (US$ million) and Volume Analysis (Units) and Forecast Projections, 2024 to 2034

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ million) And Volume Analysis (Units), By Product, 2019 to 2023

    8.3. Current and Future Market Size (US$ million) and Volume Analysis (Units) and Forecast By Product, 2024 to 2034

        8.3.1. Anesthetic Drops

        8.3.2. Dilation Drops

        8.3.3. Glaucoma Drops

        8.3.4. Steroid Drops

        8.3.5. Antibiotic Drops

        8.3.6. Others

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ million) Analysis By Indication, 2019 to 2023

    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Indication, 2024 to 2034

        9.3.1. Dry Eye

        9.3.2. Eye Allergy

        9.3.3. Glaucoma

        9.3.4. Eye Infection

        9.3.5. Retinal Disorders

            9.3.5.1. Macular Degeneration

            9.3.5.2. Diabetic Retinopathy

            9.3.5.3. Others

        9.3.6. Uveitis

        9.3.7. Others

    9.4. Market Attractiveness Analysis By Indication

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Formulation

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ million) Analysis By Drug Formulation, 2019 to 2023

    10.3. Current and Future Market Size (US$ million) and Forecast By Drug Formulation, 2024 to 2034

        10.3.1. With Preservative

        10.3.2. Preservative Free

    10.4. Market Attractiveness Analysis By Drug Formulation

11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Container Type

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ million) By Container Type, 2019 to 2023

    11.3. Current and Future Market Size (US$ million and Forecast By Container Type, 2024 to 2034

        11.3.1. Single Dose Container

        11.3.2. Multiple-dose Container

    11.4. Market Attractiveness Analysis By Container Type

12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ million) By Distribution Channel, 2019 to 2023

    12.3. Current and Future Market Size (US$ million) and Forecast By Distribution Channel, 2024 to 2034

        12.3.1. Institutional Sales

            12.3.1.1. Hospitals

            12.3.1.2. Community Clinics

            12.3.1.3. Ophthalmic Clinics

            12.3.1.4. Public Health Agencies

            12.3.1.5. Veterinary Hospitals & Clinics

        12.3.2. Retail Sales

            12.3.2.1. Retail Pharmacies

            12.3.2.2. Drug Stores

            12.3.2.3. Mail Order Pharmacy

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ million) And Volume Analysis (Units) and By Region, 2019 to 2023

    13.3. Current and Future Market Size (US$ million) and Volume Analysis (Units)and Forecast By Region, 2024 to 2034

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. East Asia

        13.3.4. South Asia & Pacific

        13.3.5. Western Europe

        13.3.6. Eastern Europe

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    14.1. Introduction

    14.2. Historical Market Size (US$ million) And Volume Analysis (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.3. Current and Future Market Size (US$ million) and Volume Analysis (Units)and Forecast By Market Taxonomy, 2024 to 2034

        14.3.1. By Country

            14.3.1.1. United States

            14.3.1.2. Canada

            14.3.1.3. Mexico

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By Drug Formulation

        14.3.5. By Container Type

        14.3.6. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Indication

        14.4.4. By Drug Formulation

        14.4.5. By Container Type

        14.4.6. By Distribution Channel

    14.5. Key Takeaways

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. United States Market Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By Indication

                14.7.1.2.3. By Drug Formulation

                14.7.1.2.4. By Container Type

                14.7.1.2.5. By Distribution Channel

        14.7.2. Canada Market Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By Indication

                14.7.2.2.3. By Drug Formulation

                14.7.2.2.4. By Container Type

                14.7.2.2.5. By Distribution Channel

        14.7.3. Mexico Market Analysis

            14.7.3.1. Introduction

            14.7.3.2. Market Analysis and Forecast by Market Taxonomy

                14.7.3.2.1. By Product

                14.7.3.2.2. By Indication

                14.7.3.2.3. By Drug Formulation

                14.7.3.2.4. By Container Type

                14.7.3.2.5. By Distribution Channel

15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    15.1. Introduction

    15.2. Historical Market Size (US$ million) And Volume Analysis (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.3. Current and Future Market Size (US$ million) and Volume Analysis (Units) and Forecast By Market Taxonomy, 2024 to 2034

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Chile

            15.3.1.3. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By Drug Formulation

        15.3.5. By Container Type

        15.3.6. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Indication

        15.4.4. By Drug Formulation

        15.4.5. By Container Type

        15.4.6. By Distribution Channel

    15.5. Key Takeaways

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Brazil Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By Indication

                15.7.1.2.3. By Drug Formulation

                15.7.1.2.4. By Container Type

                15.7.1.2.5. By Distribution Channel

        15.7.2. Chile Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By Indication

                15.7.2.2.3. By Drug Formulation

                15.7.2.2.4. By Container Type

                15.7.2.2.5. By Distribution Channel

        15.7.3. Rest of Latin America Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By Indication

                15.7.3.2.3. By Drug Formulation

                15.7.3.2.4. By Container Type

                15.7.3.2.5. By Distribution Channel

16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    16.1. Introduction

    16.2. Historical Market Size (US$ million) And Volume Analysis (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.3. Current and Future Market Size (US$ million) and Volume Analysis (Units)and Forecast By Market Taxonomy, 2024 to 2034

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By Drug Formulation

        16.3.5. By Container Type

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Indication

        16.4.4. By Drug Formulation

        16.4.5. By Container Type

        16.4.6. By Distribution Channel

    16.5. Key Takeaways

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. China Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By Indication

                16.7.1.2.3. By Drug Formulation

                16.7.1.2.4. By Container Type

                16.7.1.2.5. By Distribution Channel

        16.7.2. Japan Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By Indication

                16.7.2.2.3. By Drug Formulation

                16.7.2.2.4. By Container Type

                16.7.2.2.5. By Distribution Channel

        16.7.3. South Korea Market Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By Indication

                16.7.3.2.3. By Drug Formulation

                16.7.3.2.4. By Container Type

                16.7.3.2.5. By Distribution Channel

17. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    17.1. Introduction

    17.2. Historical Market Size (US$ million) And Volume Analysis (Units) and Trend Analysis & Forecast By Market Taxonomy, 2019 to 2023

    17.3. Current and Future Market Size (US$ million) and Volume Analysis (Units) and Forecast By Market Taxonomy, 2024 to 2034

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. AESAN Countries

            17.3.1.3. Australia & New Zealand

            17.3.1.4. Rest of South Asia & Pacific

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By Drug Formulation

        17.3.5. By Container Type

        17.3.6. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Indication

        17.4.4. By Drug Formulation

        17.4.5. By Container Type

        17.4.6. By Distribution Channel

    17.5. Key Takeaways

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. India Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By Indication

                17.7.1.2.3. By Drug Formulation

                17.7.1.2.4. By Container Type

                17.7.1.2.5. By Distribution Channel

        17.7.2. AESAN Countries Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By Indication

                17.7.2.2.3. By Drug Formulation

                17.7.2.2.4. By Container Type

                17.7.2.2.5. By Distribution Channel

        17.7.3. Australia & New Zealand Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By Indication

                17.7.3.2.3. By Drug Formulation

                17.7.3.2.4. By Container Type

                17.7.3.2.5. By Distribution Channel

        17.7.4. Rest of South Asia & Pacific Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast by Market Taxonomy

                17.7.4.2.1. By Product

                17.7.4.2.2. By Indication

                17.7.4.2.3. By Drug Formulation

                17.7.4.2.4. By Container Type

                17.7.4.2.5. By Distribution Channel

18. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    18.1. Introduction

    18.2. Historical Market Size (US$ million) And Volume Analysis (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    18.3. Current and Future Market Size (US$ million) and Volume Analysis (Units) and Forecast By Market Taxonomy, 2024 to 2034

        18.3.1. By Country

            18.3.1.1. Germany

            18.3.1.2. Italy

            18.3.1.3. France

            18.3.1.4. United Kingdom

            18.3.1.5. Spain

            18.3.1.6. BENELUX

            18.3.1.7. Nordic

            18.3.1.8. Rest of Western Europe

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By Drug Formulation

        18.3.5. By Container Type

        18.3.6. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Indication

        18.4.4. By Drug Formulation

        18.4.5. By Container Type

        18.4.6. By Distribution Channel

    18.5. Key Takeaways

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Germany Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By Indication

                18.7.1.2.3. By Drug Formulation

                18.7.1.2.4. By Container Type

                18.7.1.2.5. By Distribution Channel

        18.7.2. Italy Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By Indication

                18.7.2.2.3. By Drug Formulation

                18.7.2.2.4. By Container Type

                18.7.2.2.5. By Distribution Channel

        18.7.3. France Market Analysis

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Product

                18.7.3.2.2. By Indication

                18.7.3.2.3. By Drug Formulation

                18.7.3.2.4. By Container Type

                18.7.3.2.5. By Distribution Channel

        18.7.4. United Kingdom Market Analysis

            18.7.4.1. Introduction

            18.7.4.2. Market Analysis and Forecast by Market Taxonomy

                18.7.4.2.1. By Product

                18.7.4.2.2. By Indication

                18.7.4.2.3. By Drug Formulation

                18.7.4.2.4. By Container Type

                18.7.4.2.5. By Distribution Channel

        18.7.5. Spain Market Analysis

            18.7.5.1. Introduction

            18.7.5.2. Market Analysis and Forecast by Market Taxonomy

                18.7.5.2.1. By Product

                18.7.5.2.2. By Indication

                18.7.5.2.3. By Drug Formulation

                18.7.5.2.4. By Container Type

                18.7.5.2.5. By Distribution Channel

        18.7.6. BENELUX Market Analysis

            18.7.6.1. Introduction

            18.7.6.2. Market Analysis and Forecast by Market Taxonomy

                18.7.6.2.1. By Product

                18.7.6.2.2. By Indication

                18.7.6.2.3. By Drug Formulation

                18.7.6.2.4. By Container Type

                18.7.6.2.5. By Distribution Channel

        18.7.7. Nordic Market Analysis

            18.7.7.1. Introduction

            18.7.7.2. Market Analysis and Forecast by Market Taxonomy

                18.7.7.2.1. By Product

                18.7.7.2.2. By Indication

                18.7.7.2.3. By Drug Formulation

                18.7.7.2.4. By Container Type

                18.7.7.2.5. By Distribution Channel

19. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    19.1. Introduction

    19.2. Historical Market Size (US$ million) And Volume Analysis (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    19.3. Current and Future Market Size (US$ million) and Volume Analysis (Units)and Forecast By Market Taxonomy, 2024 to 2034

        19.3.1. By Country

            19.3.1.1. Russia

            19.3.1.2. Hungary

            19.3.1.3. Poland

            19.3.1.4. Rest of Eastern Europe

        19.3.2. By Product

        19.3.3. By Indication

        19.3.4. By Drug Formulation

        19.3.5. By Container Type

        19.3.6. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Product

        19.4.2. By Indication

        19.4.3. By Drug Formulation

        19.4.4. By Container Type

        19.4.5. By Distribution Channel

    19.5. Key Takeaways

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. Russia Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast by Market Taxonomy

                19.7.1.2.1. By Product

                19.7.1.2.2. By Indication

                19.7.1.2.3. By Drug Formulation

                19.7.1.2.4. By Container Type

                19.7.1.2.5. By Distribution Channel

        19.7.2. Hungary Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast by Market Taxonomy

                19.7.2.2.1. By Product

                19.7.2.2.2. By Indication

                19.7.2.2.3. By Drug Formulation

                19.7.2.2.4. By Container Type

                19.7.2.2.5. By Distribution Channel

        19.7.3. Poland Market Analysis

            19.7.3.1. Introduction

            19.7.3.2. Market Analysis and Forecast by Market Taxonomy

                19.7.3.2.1. By Product

                19.7.3.2.2. By Indication

                19.7.3.2.3. By Drug Formulation

                19.7.3.2.4. By Container Type

                19.7.3.2.5. By Distribution Channel

        19.7.4. Rest of Eastern Europe Market Analysis

            19.7.4.1. Introduction

            19.7.4.2. Market Analysis and Forecast by Market Taxonomy

                19.7.4.2.1. By Product

                19.7.4.2.2. By Indication

                19.7.4.2.3. By Drug Formulation

                19.7.4.2.4. By Container Type

                19.7.4.2.5. By Distribution Channel

20. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034

    20.1. Introduction

    20.2. Historical Market Size (US$ million) And Volume Analysis (Units) and Trend Analysis & Forecast By Market Taxonomy, 2019 to 2023

    20.3. Current and Future Market Size (US$ million) and Volume Analysis (Units)and Forecast By Market Taxonomy, 2024 to 2034

        20.3.1. By Country

            20.3.1.1. Saudi Arabia

            20.3.1.2. Türkiye

            20.3.1.3. South Africa

            20.3.1.4. Other African Union

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Indication

        20.3.4. By Drug Formulation

        20.3.5. By Container Type

        20.3.6. By Distribution Channel

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Indication

        20.4.4. By Drug Formulation

        20.4.5. By Container Type

        20.4.6. By Distribution Channel

    20.5. Key Takeaways

    20.6. Drivers and Restraints - Impact Analysis

    20.7. Country Level Analysis & Forecast

        20.7.1. Saudi Arabia Market Analysis

            20.7.1.1. Introduction

            20.7.1.2. Market Analysis and Forecast by Market Taxonomy

                20.7.1.2.1. By Product

                20.7.1.2.2. By Indication

                20.7.1.2.3. By Drug Formulation

                20.7.1.2.4. By Container Type

                20.7.1.2.5. By Distribution Channel

        20.7.2. Türkiye Market Analysis

            20.7.2.1. Introduction

            20.7.2.2. Market Analysis and Forecast by Market Taxonomy

                20.7.2.2.1. By Product

                20.7.2.2.2. By Indication

                20.7.2.2.3. By Drug Formulation

                20.7.2.2.4. By Container Type

                20.7.2.2.5. By Distribution Channel

        20.7.3. South Africa Market Analysis

            20.7.3.1. Introduction

            20.7.3.2. Market Analysis and Forecast by Market Taxonomy

                20.7.3.2.1. By Product

                20.7.3.2.2. By Indication

                20.7.3.2.3. By Drug Formulation

                20.7.3.2.4. By Container Type

                20.7.3.2.5. By Distribution Channel

        20.7.4. Other African Union Market Analysis

            20.7.4.1. Introduction

            20.7.4.2. Market Analysis and Forecast by Market Taxonomy

                20.7.4.2.1. By Product

                20.7.4.2.2. By Indication

                20.7.4.2.3. By Drug Formulation

                20.7.4.2.4. By Container Type

                20.7.4.2.5. By Distribution Channel

        20.7.5. Rest of Middle East and Africa Market Analysis

            20.7.5.1. Introduction

            20.7.5.2. Market Analysis and Forecast by Market Taxonomy

                20.7.5.2.1. By Product

                20.7.5.2.2. By Indication

                20.7.5.2.3. By Drug Formulation

                20.7.5.2.4. By Container Type

                20.7.5.2.5. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of top Players

    21.3. Market Presence Analysis

        21.3.1. By Regional Footprint of Players

        21.3.2. Product Footprint by Players

        21.3.3. Channel Footprint by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Branding and Promotional Strategies, By Key Players

    22.4. Key Development Analysis

    22.5. Competition Deep Dive

        22.5.1. Allergan (AbbVie)

            22.5.1.1. Overview

            22.5.1.2. Component Portfolio

            22.5.1.3. Key Financials

            22.5.1.4. Sales Footprint

            22.5.1.5. SWOT Analysis

            22.5.1.6. Key Departments

            22.5.1.7. Strategy Overview

                22.5.1.7.1. Marketing Strategies

                22.5.1.7.2. Channel Strategies

                22.5.1.7.3. Product Strategies

        22.5.2. Novartis AG (Sandoz Inc.)

        22.5.3. Alcon Laboratories, Inc.

        22.5.4. Bausch Health US LLC

        22.5.5. Viatris Inc.

        22.5.6. Teva Pharmaceuticals

        22.5.7. Sun Pharmaceutical Industries, Inc.

        22.5.8. USAPHARM Arzneimittel GmbH

        22.5.9. Lupin Biomedica Group

        22.5.10. Biomedica Group

        22.5.11. AdvaCare Pharma

        22.5.12. Dompé Farmaceutici S.p.A.

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Ophthalmic Diagnostic Equipment Market

Published : March 2024

Healthcare

Eye and Face Protection Market

Published : January 2023

Healthcare

Eye Infections Treatment Market

Published : July 2022

Healthcare

Ophthalmic Lasers Market

Published : June 2022

Explore Healthcare Insights

View Reports

Ophthalmic Eye Drop Market